Cleveland BioLabs
CBLI
#9795
Rank
A$73.26 M
Marketcap
A$4.73
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Earnings for Cleveland BioLabs (CBLI)

Earnings in 2021 (TTM): -A$3.69 Million

According to Cleveland BioLabs 's latest financial reports the company's current earnings are A$0.63 Million. In 2020 the company made an earning of -A$3.84 Million a decrease over its 2019 earnings that were of -A$3.53 Million.

Earnings history for Cleveland BioLabs from 2004 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$3.69 Million-3.98%
2020-A$3.84 Million8.8%
2019-A$3.53 Million-50.81%
2018-A$7.17 Million-14.3%
2017-A$8.37 Million-11.88%
2016-A$9.49 Million-50.9%
2015-A$19.33 Million-10.24%
2014-A$21.54 Million-37.5%
2013-A$34.46 Million-23.2%
2012-A$44.87 Million19.68%
2011-A$37.49 Million133.81%
2010-A$16.04 Million68.22%
2009-A$9.54 Million-55.51%
2008-A$21.42 Million-45.62%
2007-A$39.39 Million255.63%
2006-A$11.08 Million198.18%
2005-A$3.72 Million-1.25%
2004-A$3.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$27.11 Million 559.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-A$0.24 Billion 5,693.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.30 B-299,603.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.51 B-596,599.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
A$11.99 B-291,937.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.58 B-330,710.78%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
A$13.92 B-338,799.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$18.47 Million 349.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.60 B-817,651.66%๐Ÿ‡บ๐Ÿ‡ธ USA